JP2002523426A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002523426A5 JP2002523426A5 JP2000566308A JP2000566308A JP2002523426A5 JP 2002523426 A5 JP2002523426 A5 JP 2002523426A5 JP 2000566308 A JP2000566308 A JP 2000566308A JP 2000566308 A JP2000566308 A JP 2000566308A JP 2002523426 A5 JP2002523426 A5 JP 2002523426A5
- Authority
- JP
- Japan
- Prior art keywords
- cyanovirin
- antibody
- immunodeficiency virus
- hiv
- selecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/136,594 US6193982B1 (en) | 1995-04-27 | 1998-08-19 | Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120 |
| US09/136,594 | 1998-08-19 | ||
| PCT/US1999/018975 WO2000011036A1 (en) | 1998-08-19 | 1999-08-19 | AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002523426A JP2002523426A (ja) | 2002-07-30 |
| JP2002523426A5 true JP2002523426A5 (https=) | 2006-10-05 |
Family
ID=22473516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000566308A Pending JP2002523426A (ja) | 1998-08-19 | 1999-08-19 | ｇｐ１２０に固有の形を有する抗シアノビリン抗体、その使用方法及びシアノビリンを用いてｇｐ１２０に対する免疫応答を誘導する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6193982B1 (https=) |
| EP (1) | EP1107991A1 (https=) |
| JP (1) | JP2002523426A (https=) |
| AU (1) | AU746313B2 (https=) |
| CA (1) | CA2340787A1 (https=) |
| WO (1) | WO2000011036A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6428790B1 (en) * | 1995-04-27 | 2002-08-06 | The United States Of America As Represented By The Secretary Department Of Health And Human Services | Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use |
| US7276227B2 (en) * | 2002-02-25 | 2007-10-02 | United States Of America, Repesented By The Secretary, Department Of Health And Human Services | Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity |
| AU2003276822A1 (en) * | 2002-03-08 | 2004-02-02 | Osel, Inc. | Lactobacilli expressing biologically active polypeptides and uses thereof |
| US7491798B2 (en) * | 2002-05-16 | 2009-02-17 | The United States Of America As Represented By The Department Of Health And Human Services | Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins |
| US7358334B1 (en) | 2003-11-14 | 2008-04-15 | Jay W Chaplin | B cell-targeted toxins for humoral immune response reduction and methods of use thereof |
| US7456011B2 (en) * | 2005-01-12 | 2008-11-25 | Osel, Inc. | Modified cyanovirin-n polypeptide |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| WO2019108656A1 (en) | 2017-11-28 | 2019-06-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Microbicidal composition |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5266478A (en) | 1987-05-29 | 1993-11-30 | Tanox Biosystems, Inc. | Antibodies which target a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120 |
| US5445960A (en) | 1988-03-31 | 1995-08-29 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Monoclonal antibodies specific for HIV and hybridomas for their production |
| DE69029937T2 (de) | 1989-04-25 | 1997-05-28 | Tanox Biosystems Inc | FÜr DIE CO4-BINDENDE DOMÄNE VON HIV SPEZIFISCHE ANTIKÖRPER |
| WO1991009625A1 (en) | 1989-12-21 | 1991-07-11 | Tanox Biosystems, Inc. | Monoclonal antibodies which neutralize hiv-1 infection and their anti-idiotypes |
| SE9000333D0 (sv) | 1990-01-31 | 1990-01-31 | Britta Wahren | Monoklonal antikropp |
| EP0651818B1 (en) | 1990-05-16 | 1999-01-07 | Dana Farber Cancer Institute | Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
| AP237A (en) | 1990-05-29 | 1993-04-29 | Cedars Sinai Medical Center | Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use. |
| JP2989862B2 (ja) | 1990-07-02 | 1999-12-13 | 財団法人化学及血清療法研究所 | モノクローナル抗体 |
| AU9072991A (en) | 1990-10-26 | 1992-05-26 | Public Health Research Institute Of The City Of New York, Inc., The | Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
| AU8900691A (en) | 1990-11-19 | 1992-06-11 | Queen's University At Kingston | Hiv marker/aids vaccine |
| WO1992008491A1 (en) | 1990-11-20 | 1992-05-29 | Tanox Biosystems, Inc. | Conjugates of anti-idiotype antibodies and carriers and their use in epitope-directed immunization |
| IE920785A1 (en) | 1991-03-11 | 1992-09-23 | Idec Pharma Corp | Methods for selecting antibody reagents; anti-idiotype¹antibodies; and aids vaccine formulations |
| AU1538392A (en) | 1991-03-11 | 1992-10-06 | Idec Pharmaceuticals Corporation | Methods for selecting antibody reagents; anti-idiotype antibodies; and aids vaccine formulations |
| JPH0570493A (ja) | 1991-05-31 | 1993-03-23 | Chemo Sero Therapeut Res Inst | ヒト免疫不全ウイルス（ｈｉｖ）関連免疫調製物 |
| AU659677B2 (en) | 1991-08-22 | 1995-05-25 | Nissin Shokuhin Kabushiki Kaisha | HIV immunotherapeutics |
| US5558865A (en) | 1991-08-22 | 1996-09-24 | Nissin Shokuhin Kabushiki Kaisha | HIV immunotherapeutics |
| AU2752892A (en) | 1991-09-26 | 1993-04-27 | Oklahoma Medical Research Foundation | Fusion proteins targeted to lysosomes, for the treatment of aids |
| WO1993012232A1 (en) | 1991-12-10 | 1993-06-24 | Dana Farber Cancer Institute | Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof |
| EP0581353A1 (en) | 1992-07-03 | 1994-02-02 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur | Monoclonal antibodies to HiV-1 gp120, cell lines producing them and corresponding epitope structures |
| JPH08502260A (ja) | 1992-09-30 | 1996-03-12 | ザ スクリップス リサーチ インスティテュート | ヒト免疫不全ウイルスに対するヒト中和モノクローナル抗体 |
| US5652138A (en) | 1992-09-30 | 1997-07-29 | The Scripps Research Institute | Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| JPH06141885A (ja) | 1992-11-05 | 1994-05-24 | Chemo Sero Therapeut Res Inst | モノクローナル抗体 |
| US5817767A (en) | 1993-02-24 | 1998-10-06 | Progenics Pharmaceuticals, Inc. | Synergistic composition of CD4-based protein and anti-HIV-1 antibody, and methods of using same |
| AU7203194A (en) | 1993-06-04 | 1995-01-03 | New York University | Bispecific human monoclonal antibodies specific for human immunodeficiency virus |
| SE9302769D0 (sv) | 1993-08-27 | 1993-08-27 | Electrolux Ab | Motorstyrning |
| US5618922A (en) | 1994-07-25 | 1997-04-08 | Nissin Shokuhin Kabushiki Kaisha | NM03 antibody materials and methods |
| US5843882A (en) | 1995-04-27 | 1998-12-01 | The United States Of America As Represented By The Department Of Health And Human Services | Antiviral proteins and peptides |
-
1998
- 1998-08-19 US US09/136,594 patent/US6193982B1/en not_active Expired - Fee Related
-
1999
- 1999-08-19 AU AU56814/99A patent/AU746313B2/en not_active Ceased
- 1999-08-19 CA CA002340787A patent/CA2340787A1/en not_active Abandoned
- 1999-08-19 WO PCT/US1999/018975 patent/WO2000011036A1/en not_active Ceased
- 1999-08-19 EP EP99943784A patent/EP1107991A1/en not_active Ceased
- 1999-08-19 JP JP2000566308A patent/JP2002523426A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Takada et al. | Antibody-dependent enhancement of Ebola virus infection | |
| WO2002064615A3 (en) | Monoclonal antibodies to human immunodeficiency virus and uses thereof | |
| Weber et al. | Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity | |
| Spenlehauer et al. | Study of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell-line-adapted strains of human immunodeficiency virus type 1 | |
| WO2002020554A3 (en) | Hiv peptides from conserved regions in gag p17 and 924 and their application in e.g. vaccines | |
| BR0210598A (pt) | Complexo solúvel que compreende uma glicoproteìna retroviral de superfìcie | |
| JP2002523426A5 (https=) | ||
| ZA200107072B (en) | HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV. | |
| JP2007525465A5 (https=) | ||
| DANIELS | Mechanisms of viral neutralization | |
| ATE429248T1 (de) | Verwendung cd28 spezifischer monoklonaler antikörper zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von virusinfektionen | |
| WO2007005948A3 (en) | Methods and compositions for diagnosis and treatment of viral and bacterial infections | |
| WO2002020555A3 (en) | Hiv peptides from tat, rev and wef conserved regions and their application as e.g.vaccine components | |
| ATE285418T1 (de) | Humanisierter antikörper spezifisch für das oberflächenantigen pre-s1 von hbv und dessen präparation | |
| Tranchat et al. | Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988–1994 | |
| EP1326895B8 (fr) | Anticorps monoclonaux diriges contre des virus de l'hepatite b | |
| Prevost et al. | Augmentation of lymphocyte cytotoxicity by antibody to herpesvirus saimiri associated antigens. | |
| WO1998035694A3 (en) | A pharmaceutical composition for treating hepatitis b virus (hbv) infection | |
| ATE521640T1 (de) | Anti-tsg101-antikörper und ihre verwendungen bei der behandlung von virusinfektionen | |
| CA2130832A1 (en) | Virus-targeted biocatalysts | |
| Plantier et al. | V3 serological subtyping of human immunodeficiency virus type 2 infection is not relevant | |
| WO2000000223A3 (de) | ANTIVIRALE UND ANTIRETROVIRALE RADIOIMMUNPHARMAKA AUF DER BASIS VON α- UND β-STRAHLERN | |
| RU97109395A (ru) | Способ дифференциальной диагностики омской геморрагической лихорадки и клещевого энцефалита | |
| JP2002125678A5 (https=) | ||
| FR2874017B1 (fr) | Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih |